Tetrabenazine (TAGI Pharma, Inc.)
Welcome to the PulseAid listing for the Tetrabenazine drug offered from TAGI Pharma, Inc.. This Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | TAGI Pharma, Inc. |
NON-PROPRIETARY NAME: | Tetrabenazine |
SUBSTANCE NAME: | TETRABENAZINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-01 |
END MARKETING DATE: | 0000-00-00 |
Tetrabenazine HUMAN PRESCRIPTION DRUG Details:
Item Description | Tetrabenazine from TAGI Pharma, Inc. |
LABELER NAME: | TAGI Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5(mg/1) |
START MARKETING DATE: | 2017-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51224-425_6c0d281a-5882-4bcb-997c-6739b07c5e05 |
PRODUCT NDC: | 51224-425 |
APPLICATION NUMBER: | ANDA207682 |
Other TETRABENAZINE Pharmaceutical Manufacturers / Labelers: